
USFDA APPLICATION NUMBER - 20688 / DOSAGE - SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| OLOPATADINE HYDROCHLORIDE(UNII: 2XG66W44KF) (OLOPATADINE - UNII:D27V6190PM) | OLOPATADINE | 1mg in 1 |
Inactive Ingredients
| Ingredient Name | Alvogen Inc. | A-S Medication Solutions | Alcon Laboratories, Inc. | Apotex Corp. | Aurobindo Pharma Limited | Cipla USA Inc. | ECI Pharmaceuticals, LLC | FDC Limited | Gland Pharma Limited | Golden State Medical Supply, Inc | Mylan Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | Sandoz Inc | Somerset Therapeutics, LLC | Westminster Pharmaceuticals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BENZALKONIUM CHLORIDE (F5UM2KM3W7) | |||||||||||||||
| BENZALKONIUM CHLORIDE(F5UM2KM3W7) | |||||||||||||||
| HYDROCHLORIC ACID(QTT17582CB) | |||||||||||||||
| SODIUM CHLORIDE(451W47IQ8X) | |||||||||||||||
| SODIUM HYDROXIDE(55X04QC32I) | |||||||||||||||
| SODIUM PHOSPHATE, DIBASIC (GR686LBA74) | |||||||||||||||
| SODIUM PHOSPHATE, DIBASIC(GR686LBA74) | |||||||||||||||
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS(22ADO53M6F) | |||||||||||||||
| SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE(E1W4N241FO) | |||||||||||||||
| SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM(GR686LBA74) | |||||||||||||||
| WATER(059QF0KO0R) |